0

544445

APL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Asston Pharmaceuticals Limited Share Price Today

Investment Returns

Over 1 Month -5.45% Over 3 Months -14.10% Over 6 Months -21.88% Over 1 Year -41.56%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Asston Pharmaceuticals Limited fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 62.10
  • P/E Ratio (TTM) 16.08
  • Beta 0.26
  • Book Value / share 45.65
  • Return on equity 42.28%
  • EPS (TTM) 4.54
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.00
info icon alternate text

Asston Pharmaceuticals Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 25.47
Operating Expense 26.99
Net Profit 3.87
Net Profit Margin (%) 15.19
Earnings Per Share (EPS) 4.92
EBITDA 5.54
Effective Tax Rate (%) 15.90
Particulars MAR 2025 (Values in Cr)
Revenue 25.04
Operating Expense 20.59
Net Profit 3.85
Net Profit Margin (%) 15.37
Earnings Per Share (EPS) 6.14
EBITDA 6.01
Effective Tax Rate (%) 23.10
Particulars MAR 2024 (Values in Cr)
Revenue 15.59
Operating Expense 14.02
Net Profit 1.36
Net Profit Margin (%) 8.72
Earnings Per Share (EPS) 17.35
EBITDA 2.80
Effective Tax Rate (%) 25.27
Particulars MAR 2023 (Values in Cr)
Revenue 6.54
Operating Expense 5.77
Net Profit 1.06
Net Profit Margin (%) 16.20
Earnings Per Share (EPS) 15.09
EBITDA 2.17
Effective Tax Rate (%) 25.53
Particulars MAR 2022 (Values in Cr)
Revenue 9.60
Operating Expense 10.39
Net Profit 0.11
Net Profit Margin (%) 1.14
Earnings Per Share (EPS) 1.58
EBITDA 0.60
Effective Tax Rate (%) 31.25
Particulars MAR 2025 (Values in Cr)
Book Value / Share 17.60
ROE % 42.28
ROCE % 36.73
Total Debt to Total Equity 0.77
EBITDA Margin 24.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 91.63
ROE % 53.00
ROCE % 37.65
Total Debt to Total Equity 1.32
EBITDA Margin 25.39
Particulars MAR 2023 (Values in Cr)
Book Value / Share 28.37
ROE % 72.60
ROCE % 36.93
Total Debt to Total Equity 2.93
EBITDA Margin 33.18
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.28
ROE % 11.83
ROCE % 13.75
Total Debt to Total Equity 3.56
EBITDA Margin 6.25
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.19
Total Assets 28.12
Total Liabilities 28.12
Total Equity 11.03
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 13.69
Return on Capital (%) 21.06
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 20.26
Total Liabilities 20.26
Total Equity 6.39
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 6.71
Return on Capital (%) 10.3
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 13.69
Total Liabilities 13.69
Total Equity 1.98
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 7.71
Return on Capital (%) 14.61
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 9.49
Total Liabilities 9.49
Total Equity 0.92
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 1.16
Return on Capital (%) 2.61
Particulars MAR 2025 (Values in Cr)
Net Income 5.01
Cash from Operations 0.00
Cash from Investing 0.73
Cash from Financing -0.51
Net change in Cash 0.19
Free Cash Flow 0.01
Particulars MAR 2024 (Values in Cr)
Net Income 3.25
Cash from Operations -3.51
Cash from Investing 0.00
Cash from Financing 3.85
Net change in Cash -0.11
Free Cash Flow -3.50
Particulars MAR 2023 (Values in Cr)
Net Income 1.41
Cash from Operations -0.30
Cash from Investing -0.91
Cash from Financing 1.21
Net change in Cash -0.01
Free Cash Flow -0.05
Particulars MAR 2022 (Values in Cr)
Net Income 0.15
Cash from Operations -1.15
Cash from Investing 0.00
Cash from Financing 1.29
Net change in Cash 0.10
Free Cash Flow -1.15
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 37.20 15.37 1.80 285.08 23.12 38.85
BLISS GVS PHARMA LTD. 434.75 35.17 3.85 4599.18 118.35 442.20
CIPLA LTD 1378.90 27.30 3.23 111387.62 1165.55 1672.20
FERMENTA BIOTECH LTD. 313.40 13.82 2.26 922.37 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2188.30 36.31 16.34 37071.12 2155.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 37.20 26.01 4.79 285.08 23.12 38.85
AMRUTAJAN HEALTH LTD 555.05 24.88 4.33 1604.68 490.00 789.95
ASTRAZENECA PHARMA IND LT 8719.05 113.87 24.97 21797.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 434.75 46.75 3.98 4599.18 118.35 442.20

Asston Pharmaceuticals Limited shareholding pattern

Holding
47.42%
50.66%
1.91%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Asston Pharmaceuticals Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
73.01 4.30 redarrow
red-green-graph indicator
13 Bearish
3 Bullish
  • 5 Days 72.70
  • 26 Days 76.30
  • 10 Days 74.10
  • 50 Days 77.80
  • 12 Days 74.60
  • 100 Days 81.60
  • 20 Days 75.80
  • 200 Days 89.60
73.67 PIVOT
First Support 72.35 First Resistance 74.34 Second Support 71.68 Second Resistance 75.66 Third Support 70.36 Third Resistance 76.33
RSI 42.75 ADX 9.30 MACD -1.70 Williams % R -76.85 Commodity Channel Index (CCI) -78.98
Date 2026-05-27 Week 1000.00 Same Day 1000.00 Month 2556.00
1 Year 0.27 3 Year 0.29
Over 1 Month
-5.45% down
Over 1 Year
-41.56% down
Over 3 Months
-14.10% down
Over 3 Years
0.00% down
Over 6 Months
-21.88% down
Over 5 Years
0.00% down

Asston Pharmaceuticals Limited Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Asston Pharmaceuticals Ltd?

Answer Field

Asston Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 73.01 as on May 27 2026 12:00 AM.

What is the Market Cap of Asston Pharmaceuticals Ltd Share?

Answer Field

The market cap of Asston Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 62.10 as on May 27 2026 12:00 AM.

What is the 52 Week High and Low of Asston Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Asston Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 126.00 and ₹ 65.20.

What is 1 year return for Asston Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -41.56%.

What is the P/E Ratio of Asston Pharmaceuticals Ltd Share?

Answer Field

As on May 27 2026 12:00 AM the price-to-earnings (PE) ratio for Asston Pharmaceuticals Ltd share is 16.08.

What is the PB ratio of Asston Pharmaceuticals Ltd Share?

Answer Field

As on May 27 2026 12:00 AM, the price-to-book (PB) ratio for Asston Pharmaceuticals Ltd share is 45.65.

How to Buy Asston Pharmaceuticals Ltd Share?

Answer Field

You can trade in Asston Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Asston Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Asston Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Asston Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|